Novartis Investigative Site

Linkou District 33305

0 studies enrolling now · 9 studies all time

What they study most

Acromegaly, Acute Heart Failure, Adenocarcinoma, Carcinoma, Chronic Heart Failure, Chronic Plaque Type Psoriasis, Gastrointestinal Stromal Tumor (GIST), Hepatitis C, Hepatitis C, Chronic, Hypernephroid, Nephroid Carcinoma, Renal Cell

Studies at this site

• Global Non-interventional Heart Failure Disease Registry — Stopped early
• 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study — Stopped early
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis — Completed
• Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly — Completed
• Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. — Completed
• Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients — Completed
• A Study of Nilotinib Versus Imatinib in GIST Patients — Completed